ZLAB - Zai Lab Ltd
19.3
0.030 0.155%
Share volume: 1,136,325
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$19.27
0.03
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-06-2024 | 11-12-2024 | 02-27-2025 | 05-08-2025 | 08-07-2025 | 11-06-2025 | 02-26-2026 | |
| Assets | |||||||||
| Total Assets | 988.437 M | 987.368 M | 985.346 M | 1.186 B | 1.173 B | 1.164 B | 1.159 B | 1.172 B | |
| Current Assets | 888.640 M | 869.923 M | 860.549 M | 1.050 B | 1.042 B | 1.034 B | 1.033 B | 1.019 B | |
| Inventories | 37.851 M | 41.846 M | 39.548 M | 39.875 M | 53.054 M | 61.700 M | 67.135 M | 74.745 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 330.000 M | 0.000 | 0.000 | 0.000 | 10.000 M | |
| Total Receivables | 75.785 M | 77.737 M | 69.248 M | 89.411 M | 87.673 M | 99.342 M | 105.005 M | 118.285 M | |
| Current Cash | 650.780 M | 630.048 M | 616.086 M | 449.667 M | 757.263 M | 732.159 M | 717.155 M | 679.573 M | |
| Total Non-current Assets | 14.109 M | 4.073 M | 3.153 M | 3.115 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 52.386 M | 50.613 M | 50.765 M | 47.961 M | 49.654 M | 50.160 M | 48.868 M | 47.389 M | |
| Other Assets | 47.411 M | 66.832 M | 74.032 M | 87.312 M | 81.808 M | 79.879 M | 77.124 M | 105.709 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 988.437 M | 987.368 M | 985.346 M | 1.186 B | 1.173 B | 1.164 B | 1.159 B | 1.172 B | |
| Total liabilities | 226.268 M | 283.189 M | 317.677 M | 344.855 M | 362.577 M | 372.366 M | 398.995 M | 456.884 M | |
| Total current liabilities | 192.106 M | 251.718 M | 286.315 M | 299.385 M | 319.807 M | 331.501 M | 359.769 M | 416.166 M | |
| Accounts Payable | 88.121 M | 127.344 M | 120.652 M | 100.906 M | 103.017 M | 107.357 M | 99.706 M | 141.608 M | |
| Other liabilities | 34.162 M | 31.471 M | 6.438 M | 45.470 M | 42.770 M | 40.865 M | 11.165 M | 40.718 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 34.162 M | 31.471 M | 6.438 M | 45.470 M | 42.770 M | 40.865 M | 11.165 M | 40.718 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 762.169 M | 704.179 M | 667.669 M | 840.898 M | 810.753 M | 791.735 M | 759.945 M | 715.500 M | |
| Common stock | 2.993 B | 3.012 B | 3.032 B | 3.264 B | 3.284 B | 3.308 B | 3.328 B | 3.343 B | |
| Retained earnings | -2.249 B | -2.330 B | -2.371 B | -2.453 B | -2.502 B | -2.542 B | -2.578 B | -2.629 B |